{"title": "INFOVAC - Wichtige Nachrichten zu Impfstoffen und Impfungen", "author": null, "url": "https://www.infovac.ch/de/infovac/aktuell", "hostname": "infovac.ch", "description": "Wichtige Nachrichten zu Impfstoffen und Impfungen", "sitename": "infovac.ch", "date": "2022-12-29", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[\nGemeinsam aus der Pandemie](/de/infovac/aktuell/1012-gemeinsam-aus-der-pandemie)\n- Details\n- Datenstand : 29 Dezember 2022\nHelfen Sie pers\u00f6nlich mit: Je mehr Menschen in der Schweiz geimpft sind, desto schneller ist die Pandemie beendet.\nDie Impfung sch\u00fctzt Sie selbst vor einer schweren Covid-19-Erkrankung. Und sie reduziert das Risiko, dass Sie das Virus verbreiten und an andere weitergeben.\nWieso braucht es die Impfung?\nDas Coronavirus ist sehr ansteckend. Bei einem Teil der Erkrankten kommt es zu schweren Verl\u00e4ufen. \u00dcber 90 % der Patientinnen und Patienten auf den Intensivstationen sind Ungeimpfte. Ansteckungen k\u00f6nnen auch zu Langzeitfolgen f\u00fchren: Zu den Symptomen von Long Covid geh\u00f6ren Atemnot, Ersch\u00f6pfung und verringerte Leistungsf\u00e4higkeit. Davon k\u00f6nnen Jugendliche und Erwachsene betroffen sein.\nWas bringt die Impfung?\nAlle in der Schweiz zugelassenen Impfstoffe haben eine sehr hohe Wirksamkeit und sch\u00fctzen Sie vor einer schweren Covid-19-Erkrankung. Die Impfung reduziert auch das Risiko,\n[das Virus weiterzugeben](/de/faq/herdenimmunitaet) \u2013 so k\u00f6nnen Sie sich selbst und besonders gef\u00e4hrdete Personen in Ihrer Familie, Ihrem Haushalt, Ihrem Freundeskreis oder Ihrem Arbeitsumfeld sch\u00fctzen. Je mehr Personen geimpft sind, desto weniger zirkuliert das Virus in der Gesellschaft und desto weniger Menschen erkranken oder sterben am Coronavirus.\nDie Vorteile der Impfung auf einen Blick:\n- Sie minimiert das Risiko einer Ansteckung mit dem Coronavirus.\n- Sie verhindert schwere Verl\u00e4ufe von Covid-19 und Langzeitfolgen.\n- Sie senkt das Risiko, das Virus weiterzugeben.\n- Sie entlastet so das Gesundheitswesen.\n- Sie tr\u00e4gt dazu bei, dass mehr Freiheiten im Alltag m\u00f6glich werden.\nWie funktioniert die Impfung?\nDie Covid-19-Impfung erm\u00f6glicht dem K\u00f6rper, eine speziell gegen das Virus gerichtete Immunabwehr aufzubauen. Sobald der K\u00f6rper dem Virus ausgesetzt ist, kann er es so bek\u00e4mpfen und eine Erkrankung verhindern.\nDie Impfung st\u00e4rkt und trainiert also unser Immunsystem ganz gezielt gegen das Coronavirus.\nWelche Impfstoffe stehen zur Verf\u00fcgung?\nIn der Schweiz stehen zurzeit zwei mRNA-Impfstoffe und ein Vektorimpfstoff\nzur Verf\u00fcgung. Wie diese funktionieren, erfahren Sie hier:\nEs gibt verschiedene Ans\u00e4tze f\u00fcr die Entwicklung eines Impfstoffes gegen das Virus SARS-CoV2. Swissmedic erkl\u00e4rt die Unterschiede\nEs gibt verschiedene Wege, wie ein Impfstoff einen Menschen gegen Krankheitserreger sch\u00fctzen kann. Hier schauen wir uns den Ansatz eines viralen Vektor-Impfstoffs an.\nIst die Impfung sicher?\nJeder Impfstoff braucht in der Schweiz eine Zulassung. Dazu muss er hohe Anforderungen an Sicherheit, Wirksamkeit und Qualit\u00e4t erf\u00fcllen.\nDas Schweizerische Heilmittelinstitut Swissmedic hat die Impfstoffe gegen Covid-19 genau gepr\u00fcft und zugelassen. Sie sind sicher und wirken.\nWem wird die Impfung empfohlen?\n- Allen Personen ab 12 Jahren\n- Schwangeren Frauen (zum Schutz der Mutter und des Ungeborenen) und stillenden Frauen\n- Genesenen (nur eine Impfdosis n\u00f6tig, da eine Infektion wie eine Impfdosis wirkt)\nF\u00fcr Jugendliche im Alter von 12 bis 17 Jahren, schwangere und stillende Frauen sowie Personen mit geschw\u00e4chtem Immunsystem sind nur die mRNA-Impfstoffe empfohlen.\nWo kann ich mich impfen lassen?\nDie Impfung kann in Impfzentren, Spit\u00e4lern oder Apotheken, beim Hausarzt oder bei der Haus\u00e4rztin und im Rahmen von mobilen Angeboten durchgef\u00fchrt werden. Erkundigen Sie sich jetzt nach Impfterminen in Ihrem Wohnkanton:\n[https://bag-coronavirus.ch/kantone](https://bag-coronavirus.ch/impfung/impfung-planen/#cantons)\nWo finde ich weitere Infos?\n[Auf dieser Website](/de/impfunge/nach-krankheiten-geordnet/coronavirus-covid-19) und auf [https://bag-coronavirus.ch/impfung](https://bag-coronavirus.ch/impfung) finden Sie alle wichtigen Informationen, Adressen und Downloads.\nDazu geh\u00f6ren:\n- Informations- und Erkl\u00e4rvideos rund um die Impfung\n- Fakten zur Impfung\n- Informationen rund ums Covid-Zertifikat\n- Infomaterialien als Download\n- Informationen rund ums Reisen\nInfoline Covid-19-Impfung : 0800 88 66 44\nInformationen zur Impfung in anderen Sprachen:\n[https://foph-coronavirus.ch/languages](https://foph-coronavirus.ch/languages)", "language": null, "image": null, "pagetype": "article", "links": ["/", "/", "/de/", "/de/infovac", "/de/infovac/wer-sind-wir", "/de/infovac/infovac-fuer-alle", "/de/infovac/infovac-fuer-fachleute", "/de/infovac/infovac-fuer-fachleute/sich-einschreiben", "/de/infovac/aktuell", "/de/impfungen", "/de/impfungen/schweizerischer-impfplan", "/de/impfungen/schweizerischer-impfplan/basisimpfungen", "/de/impfungen/schweizerischer-impfplan/ergaenzende-impfungen", "/de/impfungen/schweizerischer-impfplan/risiko-impfungen", "/de/impfungen/impfstoffe-nach-krankheiten-geordnet", "/de/impfungen/impfstoffe-gemaess-einem-profil", "/de/impfungen/impfstoffe-gemaess-einem-profil/nach-alter", "/de/impfungen/impfstoffe-gemaess-einem-profil/nach-dem-ansteckungsrisiko", "/de/impfungen/impfstoffe-gemaess-einem-profil/nach-dem-komplikationsrisiko", "/de/impfungen/wirksamkeit-der-impfstoffe", "/de/impfungen/nebenwirkungen-der-impfstoffe", "/de/impfungen/meldungen", "/de/impfungen/in-der-schweiz-verfuegbare-impfstoffe", "/de/faq", "/de/faq/dokumente-und-nuetzliche-links", "/de/faq/wieso-impfen", "/de/faq/entwicklung-von-impfstoffen", "/de/faq/aluminium-in-impfstoffen", "/de/faq/epidemien", "/de/faq/herdenimmunitaet", "/de/faq/impfzwang", "/de/faq/impfungen-fuer-erwachsene", "/de/faq/kosten-der-impfstoffe", "/de/faq/kontraindikationen-fuer-impfungen", "/de/faq/hilfsstoffe", "/de/faq/immunoseneszenz", "/de/faq/nuetzlichkeit-der-impfungen", "/de/faq/wirksamkeit-von-impfungen", "/de/faq/nebenwirkungen", "/de/login", "https://www.infovac.ch/de/infovac/aktuell", "/fr/infovac/actualites", "/it/infovac/attualita", "/de/", "/de/infovac", "/de/infovac/aktuell/1012-gemeinsam-aus-der-pandemie", "/de/faq/herdenimmunitaet", "https://bag-coronavirus.ch/impfung/impfung-planen/#cantons", "/de/impfunge/nach-krankheiten-geordnet/coronavirus-covid-19", "https://bag-coronavirus.ch/impfung", "https://foph-coronavirus.ch/languages", "/de/infovac/aktuell/996-impfstoffe-gegen-covid-19-einige-antworten-auf-viele-fragen", "/de/infovac/aktuell/969-impfstoffe-gegen-covid-19-liste-der-klinischen-versuche", "https://clinicaltrials.gov/ct2/show/NCT04470427?term=moderna&phase=2&draw=2&rank=1", "https://www.nejm.org/doi/full/10.1056/NEJMoa2035389", "https://www.nejm.org/doi/full/10.1056/NEJMc2103916", "https://www.nejm.org/doi/full/10.1056/NEJMc2103740", "https://www.nejm.org/doi/full/10.1056/NEJMoa2104983", "https://www.nejm.org/doi/full/10.1056/NEJMoa2107058", "https://www.nejm.org/doi/full/10.1056/NEJMoa2109522", "https://clinicaltrials.gov/ct2/show/NCT04368728", "https://www.nejm.org/doi/full/10.1056/NEJMoa2034577", "https://www.nejm.org/doi/full/10.1056/NEJMoa2101765", "https://www.nejm.org/doi/full/10.1056/NEJMoa2104983", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00947-8/fulltext", "https://www.nejm.org/doi/full/10.1056/NEJMc2104974", "https://www.nejm.org/doi/full/10.1056/NEJMoa2107456", "https://www.nejm.org/doi/full/10.1056/NEJMoa2107058", "https://www.nejm.org/doi/full/10.1056/NEJMoa2108891", "https://www.nejm.org/doi/full/10.1056/NEJMoa2110475", "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-positive-topline-results", "/de/infovac/aktuell/950-vaccins-contre-covid-19-resultats-interimaires-d-efficacite-et-de-securite-2", "https://clinicaltrials.gov/ct2/show/NCT04505722?term=Johnson&cond=Covid19&draw=2&rank=37", "https://www.nejm.org/doi/10.1056/NEJMoa2034201", "https://jamanetwork.com/journals/jama/fullarticle/2777598", "https://www.nejm.org/doi/full/10.1056/NEJMc2105869", "https://www.nejm.org/doi/full/10.1056/NEJMc2106075", "https://www.nejm.org/doi/full/10.1056/NEJMoa2101544", "https://clinicaltrials.gov/ct2/show/NCT04449276?cond=COVID-19&phase=0&draw=3&rank=112", "https://www.curevac.com/en/2021/06/16/curevac-provides-update-on-phase-2b-3-trial-of-first-generation-covid-19-vaccine-candidate-cvncov/", "https://www.swissmedic.ch/swissmedic/de/home/news/coronavirus-covid-19/curevac-zieht-zl-gesuch-zurueck.html", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00677-0/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04583995?term=Novavax&draw=2&rank=22", "https://www.nejm.org/doi/full/10.1056/NEJMoa2107659", "https://ir.novavax.com/2021-12-17-Novavax-and-Serum-Institute-of-India-Announce-World-Health-Organization-Grants-Emergency-Use-Listing-for-NVX-CoV2373-COVID-19-Vaccine", "https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines", "https://clinicaltrials.gov/ct2/show/NCT04456595?term=vaccine&cond=COVID-19&phase=2&draw=2", "http://www.chictr.org.cn/showprojen.aspx?proj=52227", "https://clinicaltrials.gov/ct2/show/NCT04560881?term=vaccine&cond=covid-19&draw=2", "https://clinicaltrials.gov/ct2/show/NCT04505722?term=Johnson&cond=Covid19&draw=2&rank=37", "http://www.chictr.org.cn/showprojen.aspx?proj=52006", "https://clinicaltrials.gov/ct2/show/NCT04436471?term=vaccine&cond=COVID-19&phase=0&draw=2&rank=15", "http://www.chictr.org.cn/showprojen.aspx?proj=56651", "https://clinicaltrials.gov/ct2/show/NCT04636697?term=Medicago&draw=2&rank=3", "http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057&EncHid=&userName=sars-cov-2%20vaccine", "https://clinicaltrials.gov/ct2/show/NCT04445194?term=longcom&draw=2", "https://clinicaltrials.gov/ct2/show/NCT04655625", "https://clinicaltrials.gov/ct2/show/NCT04412538?cond=COVID-19&phase=0&draw=2&rank=49", "https://clinicaltrials.gov/ct2/show/NCT04672395", "http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306&EncHid=&userName=vaccine", "https://www.clinicaltrials.gov/ct2/show/NCT04530357?term=NCT04530357&draw=2&rank=1", "https://clinicaltrials.gov/ct2/show/NCT04683224", "https://www.clinicaltrials.gov/ct2/show/NCT04527575", "https://covid19.trackvaccines.org/vaccines/", "https://clinicaltrials.gov/ct2/show/NCT04352608?cond=COVID-19&phase=0&draw=2&rank=21", "https://clinicaltrials.gov/ct2/show/NCT04456595?term=vaccine&cond=COVID-19&phase=2&draw=2&rank=1", "http://www.sinovacbio.com/", "https://www.reuters.com/article/us-health-coronavirus-sinovac-trial/chinas-sinovac-to-test-coronavirus-vaccine-candidate-in-teenagers-children-idUSKBN2680CI", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30843-4/fulltext", "https://www.nature.com/articles/d41586-021-00094-z", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30987-7/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04412538?cond=COVID-19&phase=0&draw=2&rank=49", "http://english.cas.cn/newsroom/news/", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1703/5962856", "https://www.sciencedirect.com/science/article/pii/S0264410X2100431X?via%3Dihub", "http://www.chictr.org.cn/showprojen.aspx?proj=52227", "http://www.chictr.org.cn/searchprojen.aspx?title=&officialname=&subjectid=&secondaryid=&applier=&studyleader=&ethicalcommitteesanction=&sponsor=&studyailment=COVID-19&studyailmentcode=&studytype=1&studystage=0&studydesign=0&minstudyexecutetime=&maxstudyexecutetime=&recruitmentstatus=0&gender=0&agreetosign=&secsponsor=&regno=&regstatus=0&country=&province=&city=&institution=&institutionlevel=&measure=&intercode=&sourceofspends=&createyear=0&isuploadrf=&whetherpublic=&btngo=btn&verifycode=&page=1", "http://www.chinacdc.cn/en/", "https://jamanetwork.com/journals/jama/fullarticle/2769612?resultClick=1", "http://www.chictr.org.cn/showproj.aspx?proj=53003", "https://clinicaltrials.gov/ct2/show/NCT04560881?term=vaccine&cond=covid-19&draw=2", "http://www.chinacdc.cn/en/", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30831-8/fulltext", "http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=45184&EncHid=&userName=bbv152", "https://www.bharatbiotech.com/images/press/Bharat-biotech-starts-phase-III-trials-for-covaxin.pdf", "https://www.bharatbiotech.com/press_releases.html", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30942-7/fulltext", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00070-0/fulltext", "https://www.clinicaltrials.gov/ct2/show/NCT04530357?term=NCT04530357&draw=2&rank=1", "https://www.biosafety.kz/en/?itemid=229", "http://www.chictr.org.cn/showprojen.aspx?proj=62350", "http://www.chinacdc.cn/en/", "https://clinicaltrials.gov/ct2/show/NCT04671017", "https://valneva.com/research-development/covid-19-vla2001/", "https://clinicaltrials.gov/ct2/show/NCT04691947", "https://clinicaltrials.gov/ct2/show/NCT04691947", "https://www.tuseb.gov.tr/", "https://clinicaltrials.gov/ct2/show/NCT04368988?cond=COVID-19&phase=0&draw=2&rank=11", "https://clinicaltrials.gov/ct2/show/NCT04533399?term=Novavax&draw=2&rank=22", "https://clinicaltrials.gov/ct2/show/NCT04583995?term=Novavax&draw=2&rank=22", "https://clinicaltrials.gov/ct2/show/NCT04583995?term=Novavax&draw=2&rank=22", "http://ir.novavax.com/press-releases", "https://www.nejm.org/doi/full/10.1056/NEJMoa2026920", "http://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3", "http://ir.novavax.com/news-releases/news-release-details/novavax-confirms-high-levels-efficacy-against-original-and", "https://clinicaltrials.gov/ct2/show/NCT04405908?term=CpG+1018&draw=2&rank=5", "https://clinicaltrials.gov/ct2/show/NCT04672395", "http://www.cloverbiopharma.com/", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00241-5/fulltext", "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379861&isReview=true", "https://research.uq.edu.au/research/area/vaccine-and-drugs", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00200-0/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04450004?term=vaccine&cond=COVID-19&phase=0&draw=2&rank=5", "https://clinicaltrials.gov/ct2/show/NCT04636697?term=Medicago&draw=2&rank=3", "https://medicago.com/en/", "https://clinicaltrials.gov/ct2/show/NCT04445194?term=longcom&draw=2", "https://clinicaltrials.gov/ct2/show/NCT04466085?term=NCT04466085&draw=2&rank=1", "http://en.zhifeishengwu.com/about/zfgk/", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00127-4/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04473690?term=NCT04473690&draw=2&rank=1", "https://kentuckybioprocessing.com/", "https://www.clinicaltrials.gov/ct2/show/NCT04695652", "http://www.medigenvac.com/public/en", "https://clinicaltrials.gov/ct2/show/NCT04522089", "http://www.adimmune.com.tw/en/news_archives.php", "https://www.clinicaltrials.gov/ct2/show/NCT04527575", "http://www.vector.nsc.ru/", "https://clinicaltrials.gov/ct2/show/NCT04537208", "https://www.sanofi.com/fr/media-room/communiques-de-presse/2020", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00147-X/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04530656?term=NCT04530656&draw=2&rank=1", "http://www.chinacdc.cn/en/", "https://clinicaltrials.gov/ct2/show/NCT04683224", "https://vaxxinity.com/", "https://clinicaltrials.gov/ct2/show/NCT04546841?term=04546841&draw=2&rank=1", "https://uni-tuebingen.de/universitaet/infos-zum-coronavirus/forschung-zum-coronavirus/#c1066839", "https://rpcec.sld.cu/en/trials/RPCEC00000332-En", "https://www.finlay.edu.cu/en/", "https://www.clinicaltrials.gov/ct2/show/NCT04683484", "https://nanogenpharma.com/news", "https://clinicaltrials.gov/ct2/show/NCT04702178", "https://www.vido.org/covid19/covid-19-vaccine-trials", "https://clinicaltrials.gov/ct2/show/NCT04742738", "https://www.skbioscience.co.kr/kr/news/news_01", "https://clinicaltrials.gov/ct2/show/NCT04516746", "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB", "https://clinicaltrials.gov/ct2/show/NCT04516746", "http://www.ox.ac.uk/news-and-events/for-journalists", "/de/infovac/aktuell/950-impfstoffe-gegen-covid-19-zwischenergebnisse-zu-wirksamkeit-und-sicherheit", "https://clinicaltrials.gov/ct2/show/NCT04436276?term=NCT04436276&draw=2&rank=1", "https://clinicaltrials.gov/ct2/show/NCT04505722", "https://www.janssen.com/covid19", "https://www.nejm.org/doi/10.1056/NEJMoa2034201", "https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial", "https://jamanetwork.com/journals/jama/fullarticle/2777598", "https://www.nejm.org/doi/full/10.1056/NEJMc2105869", "https://www.nejm.org/doi/full/10.1056/NEJMc2106075", "https://www.nejm.org/doi/full/10.1056/NEJMoa2101544", "http://www.chictr.org.cn/showprojen.aspx?proj=52006", "https://clinicaltrials.gov/ct2/show/NCT04341389", "https://clinicaltrials.gov/ct2/show/NCT04526990?term=Ad5-nCoV&draw=2&rank=3", "https://clinicaltrials.gov/ct2/show/NCT04398147?cond=COVID-19&phase=0&draw=2&rank=74", "http://www.cansinotech.com/", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04436471?term=vaccine&cond=COVID-19&phase=0&draw=2&rank=15", "https://clinicaltrials.gov/ct2/show/NCT04437875?term=vaccine&cond=COVID-19&phase=0&draw=2&rank=17", "https://clinicaltrials.gov/ct2/show/NCT04530396", "https://sputnikvaccine.com/newsroom/pressreleases/", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/fulltext", "https://sputnikvaccine.com/newsroom/pressreleases/the-first-interim-data-analysis-of-the-sputnik-v-vaccine-against-covid-19-phase-iii-clinical-trials-/", "https://sputnikvaccine.com/newsroom/pressreleases/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d/", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext", "https://www.clinicaltrials.gov/ct2/show/NCT04498247", "https://www.mrknewsroom.com/newsroom/news-releases/vaccine-news/default.aspx", "https://clinicaltrials.gov/ct2/show/NCT04497298?term=04497298&draw=2&rank=1", "https://www.pasteur.fr/en/press-area", "https://www.clinicaltrials.gov/ct2/show/NCT04528641?term=NCT04528641&draw=2&rank=1", "https://www.reithera.com/", "https://clinicaltrials.gov/ct2/show/NCT04563702?term=NCT04563702&draw=2&rank=1", "https://vaxart.com/news/", "https://clinicaltrials.gov/ct2/show/NCT04569786", "https://www.mrknewsroom.com/newsroom/news-releases/vaccine-news/default.aspx", "https://clinicaltrials.gov/ct2/show/NCT04569383", "https://www.uke.de/allgemein/presse/index.html", "https://clinicaltrials.gov/ct2/show/NCT04591717", "https://immunitybio.com/category/press-releases/", "https://www.clinicaltrials.gov/ct2/show/NCT04608305", "https://iibr.gov.il/Covid19/Pages/ScientificPublications.aspx", "https://clinicaltrials.gov/ct2/show/NCT04639466", "https://www.cityofhope.org/research/research-news", "https://clinicaltrials.gov/ct2/show/NCT04666012", "http://www.cellid.co.kr/eng/contact/e02", "https://clinicaltrials.gov/ct2/show/NCT04276896?cond=COVID-19&phase=0&draw=3&rank=14", "http://szgimi.org/en/news.php", "https://clinicaltrials.gov/ct2/show/NCT04299724?cond=COVID-19&phase=0&draw=2&rank=6", "http://szgimi.org/en/news.php", "https://clinicaltrials.gov/ct2/show/NCT04334980?cond=COVID-19&phase=0&draw=2&rank=3", "https://www.symvivo.com/", "/de/faq/entwicklung-von-impfstoffen#Boten-RNA", "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE", "https://clinicaltrials.gov/ct2/show/NCT04368728?term=NCT04368728&draw=2&rank=1", "https://clinicaltrials.gov/ct2/show/NCT04368728", "https://www.businesswire.com/news/home/20200912005013/en/", "https://investors.biontech.de/press-releases", "/de/infovac/aktuell/950-impfstoffe-gegen-covid-19-zwischenergebnisse-zu-wirksamkeit-und-sicherheit", "https://clinicaltrials.gov/ct2/show/NCT04283461?term=vaccine&cond=covid-19&draw=2", "https://clinicaltrials.gov/ct2/show/NCT04405076?term=moderna&cond=covid-19&draw=2&rank=1", "https://clinicaltrials.gov/ct2/show/NCT04470427?term=moderna&phase=2&draw=2&rank=1", "https://www.modernatx.com/cove-study", "/de/infovac/aktuell/950-impfstoffe-gegen-covid-19-zwischenergebnisse-zu-wirksamkeit-und-sicherheit", "https://clinicaltrials.gov/ct2/show/NCT04336410?type=Intr&cond=COVID-19&phase=014&draw=3&rank=115", "https://clinicaltrials.gov/ct2/show/NCT04642638?term=Inovio&draw=2&rank=1", "https://www.inovio.com/our-focus-serving-patients/covid-19/", "https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext", "https://clinicaltrials.gov/ct2/show/NCT04445389?term=vaccine&cond=covid-19&draw=3", "http://www.genexine.com/", "https://clinicaltrials.gov/ct2/show/NCT04463472?term=NCT04463472&draw=2&rank=1", "https://www.anges.co.jp/en/", "http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306&EncHid=&userName=vaccine", "https://zyduscadila.com/", "http://www.isrctn.com/ISRCTN17072692", "http://www.imperial.ac.uk/news", "http://www.imperial.ac.uk/news", "https://clinicaltrials.gov/ct2/show/NCT04449276?cond=COVID-19&phase=0&draw=3&rank=112", "https://clinicaltrials.gov/ct2/show/NCT04515147", "https://www.curevac.com/covid-19", "https://www.reuters.com/article/health-coronavirus-germany-curevac/update-1-curevacs-covid-19-vaccine-triggers-immune-response-in-phase-i-trial-idUSL1N2HO0UI", "http://www.chictr.org.cn/showprojen.aspx?proj=55524", "http://www.walvax.com/Model/25.aspx", "https://clinicaltrials.gov/ct2/show/NCT04480957", "https://ir.arcturusrx.com/press-releases", "https://clinicaltrials.gov/ct2/show/NCT04566276", "https://www.chula.ac.th/en/news-and-knowledge/cu-news/", "https://clinicaltrials.gov/ct2/show/NCT04591184", "https://clinicaltrials.gov/ct2/show/NCT04447781?term=NCT04447781&draw=2&rank=1", "https://www.entospharma.com/news", "https://clinicaltrials.gov/ct2/show/NCT04627675?term=NCT04627675&draw=2&rank=1", "https://clinicaltrials.gov/ct2/show/NCT04447781?term=NCT04447781&draw=2&rank=1", "https://www.providence.org/news/coronavirus-blog", "https://clinicaltrials.gov/ct2/show/NCT04673149", "https://clinicaltrials.gov/ct2/show/NCT04447781?term=NCT04447781&draw=2&rank=1", "http://genels.com/en/sub/pipeline/pipe.asp", "https://clinicaltrials.gov/ct2/show/NCT04380532?term=immunitor&draw=2&rank=11", "http://www.immunitor.com/news.php", "https://clinicaltrials.gov/ct2/show/NCT04386252?term=aivita&draw=2&rank=1", "https://aivitabiomedical.com/pressmedia/", "https://clinicaltrials.gov/ct2/show/NCT04677660", "https://www.takeda.com/newsroom/", "/de/infovac/aktuell/950-impfstoffe-gegen-covid-19-zwischenergebnisse-zu-wirksamkeit-und-sicherheit", "/de/infovac/aktuell/826-coronavirus-covid-19", "/de/infovac/aktuell/814-zeckenenzephalitis-2019-ausweitung", "/de/infovac/aktuell?start=3", "/de/infovac/aktuell?start=6", "/de/infovac/aktuell?start=3", "/de/infovac/aktuell?start=6", "/de/infovac/wer-sind-wir", "/de/infovac/infovac-fuer-alle", "/de/infovac/infovac-fuer-fachleute", "/de/infovac/aktuell", "https://vaccinesafetynet.org/", "https://vaccinesafetynet.org/", "/de/kontakt", "/de/sitemap", "/de/erwahnungen-von-rechten", "/de/datenschutzerklaerung", "/de/cookies", "#", "https://www.bag.admin.ch/bag/fr/home.html", "https://www.paediatrieschweiz.ch/?lang=de", "http://www.sginf.ch/", "https://ssai.ch/", "http://www.unige.ch/medecine/", "https://www.bag.admin.ch/bag/fr/home.html", "https://www.paediatrieschweiz.ch/?lang=de", "http://www.sginf.ch/", "http://ssai.ch/index.php?id=2&L=1", "http://www.unige.ch/medecine/", "https://www.i-media.ch/", "#", "#", "#", "#", "#", "mailto:?subject=Check out this page: Aktuell&body=https://www.infovac.ch/de/infovac/aktuell", "#", "#", "#", "#", "#", "mailto:?subject=Check out this page: Aktuell&body=https://www.infovac.ch/de/infovac/aktuell", "#"]}